Broker-Dealer AgreementBroker-Dealer Agreement • February 11th, 2022 • Endonovo Therapeutics, Inc. • Pharmaceutical preparations
This agreement (together with exhibits and schedules, the “Agreement”) is entered into by and between Endonovo Therapeutics, Inc. (“Client”), a Delaware Corporation, and Dalmore Group, LLC., a New York Limited Liability Company (“Dalmore”). Client and Dalmore agree to be bound by the terms of this Agreement, effective as of February 3, 2022 (the “Effective Date”):
